stars 1 stars 2 stars 3

Genetic Signatures is an established, global molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing to provide configurable, clinically relevant MDx solutions for infectious diseases. A diverse range of assays are available under the EasyScreen™ brand, for the flexible detection of over 100 pathogens impacting global health. The EasyScreen™ kits are underpinned by Genetic Signatures’ innovative 3base™ technology, which transforms natural genetic sequences into a 3base™ sequence of A, T and C which improves multiplex efficiency and reduces the genetic complexity of detecting pathogens. This is particularly beneficial for detecting pathogen subtypes and providing increased resistance to mutation or variants, such as SARS-CoV-2. Genetic Signatures’ flexible syndromic approach provides a timely and accurate diagnosis that enhances efficiencies within the laboratory. Customers trust Genetic Signatures’ assay and workflow reliability which is supported by the Company’s high service standards and genuine partnership for driving improved patient outcomes. Genetic Signatures’ EasyScreen™ products are accessible in over 30 countries, with direct representation in the United States, United Kingdom, Germany, and Australia, and distribution partners in Canada, South America, Africa and other European nations. Products are used for IVD use and research purposes. As an employer, Genetic Signatures is proud of their highly rated and diverse workplace culture, and is committed to providing equal employment opportunities and professional development. Visit www.geneticsignatures.com for more information or email marketing@geneticsignatures.com to contact your local specialist. #moleculardiagnostics #pathology #PCR #multiplex #infectiousdisease #3base

Website http://www.geneticsignatures.com
Ticker GSS
Revenue $6.1 million
Employees 78 (78 on RocketReach)
Founded 2001
Address 7 Eliza St, Newtown, New South Wales 2042, AU
Phone +61 2 9870 7580
Fax +61 2 9889 4034
Technologies
Industry Biotechnology Research, Business Services General, Biotechnology, Molecular Diagnostics, Business Services, Science and Engineering, Infectious Disease Detection, Real-Time PCR, Pathogen Detection, Enteric Pathogen Detection, 3Base Technology
Web Rank 21 Million
Keywords Molecular Diagnostics, Assay Development, Infectious Disease Testing, Genetic Testing, Clinical Diagnostics, Molecular Testing, Diagnostic Assays, Infectious Disease Diagnostics, Clinical Microbiology, Pathogen Detection, In Vitro Diagnostics, Medical Diagnostics, Diagnostic Tools, Disease Diagnostics
Competitors Thermo Fisher Scientific, Illumina, Roche, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, LGC, GenMark Diagnostics, Hologic, Inc., Cepheid +41 more (view full list)
SIC SIC Code 87 Companies, SIC Code 873 Companies
NAICS NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies

Genetic Signatures Questions

The Genetic Signatures annual revenue was $6.1 million in 2026.

Maria Halasz is the CEO of Genetic Signatures.

78 people are employed at Genetic Signatures.

Genetic Signatures is based in Newtown, New South Wales.

The NAICS codes for Genetic Signatures are [541, 5417, 54, 54171, 541713].

The SIC codes for Genetic Signatures are [87, 873].

Top Genetic Signatures Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users